Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis

Documenti analoghi

• The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
  di: Lorente, Leonardo, et al.
  Pubblicazione: (2015)
• Influence of TIMP-1/MMP-9 ratio on the severity and mortality in sepsis
  di: Lorente, L, et al.
  Pubblicazione: (2010)
• Influence of TIMP-1/MMP-9 ratio on the severity and mortality in sepsis
  di: Lorente, L, et al.
  Pubblicazione: (2011)
• Epidemiology and outcome of patients with severe sepsis in six Spanish ICUs
  di: Lorente, L, et al.
  Pubblicazione: (2009)
• The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis
  di: Lorente, Leonardo, et al.
  Pubblicazione: (2013)